Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004-2015

Autor: Sapna Bamrah Morris, Gail Grant, Smita Ghosh, Jonathan M. Wortham, Jorge L. Salinas, Maryam B. Haddad, David Ashkin, Zimy Wansaula, Adam J. Langer, Godwin Mindra
Rok vydání: 2019
Předmět:
Microbiology (medical)
Male
medicine.medical_specialty
Tuberculosis
Genotype
Epidemiology
Mycobacterium bovis BCG
030231 tropical medicine
Public health interventions
lcsh:Medicine
Disease
complex mixtures
History
21st Century
lcsh:Infectious and parasitic diseases
03 medical and health sciences
0302 clinical medicine
Clinical history
Internal medicine
Bacillus Calmette-Guérin
Mycobacterium bovis–BCG
Medicine
Humans
lcsh:RC109-216
BCG
030212 general & internal medicine
bacteria
Disease Notification
Mycobacterium bovis
Bladder cancer
biology
business.industry
Public health
lcsh:R
fungi
food and beverages
medicine.disease
biology.organism_classification
United States
public health surveillance
tuberculosis and other mycobacteria
Infectious Diseases
TB
tuberculosis
Population Surveillance
BCG Vaccine
Synopsis
Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System
United States
2004–2015
Female
business
Zdroj: Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 25, Iss 3, Pp 451-456 (2019)
ISSN: 1080-6059
Popis: TOC summary: Clinical history can discern probable BCG cases from TB cases, enabling optimal clinical management.
Mycobacterium bovis bacillus Calmette-Guérin (BCG) is used as a vaccine to protect against disseminated tuberculosis (TB) and as a treatment for bladder cancer. We describe characteristics of US TB patients reported to the National Tuberculosis Surveillance System (NTSS) whose disease was attributed to BCG. We identified 118 BCG cases and 91,065 TB cases reported to NTSS during 2004–2015. Most patients with BCG were US-born (86%), older (median age 75 years), and non-Hispanic white (81%). Only 17% of BCG cases had pulmonary involvement, in contrast with 84% of TB cases. Epidemiologic features of BCG cases differed from TB cases. Clinicians can use clinical history to discern probable BCG cases from TB cases, enabling optimal clinical management. Public health agencies can use this information to quickly identify probable BCG cases to avoid inappropriately reporting BCG cases to NTSS or expending resources on unnecessary public health interventions.
Databáze: OpenAIRE
Externí odkaz: